Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Aronsson

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Human Reproduction (Oxford, England)|July 27, 2007
Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trialI Sääv, A Aronsson, L Marions, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|January 1, 1996
In vivo effects of 13-cis retinoic acid treatment on the concentration of proteins and lipids in serumG A Fex, A Aronsson, A Andersson, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|September 12, 2017
Vaginal breech delivery at term and neonatal morbidity and mortality - a population-based cohort study in SwedenC Ekéus, M Norman, K Åberg, et al.
European Journal of Clinical Nutrition|July 30, 2009
Ability of physical activity measurements to assess health-related risksC Li, C A Aronsson, B Hedblad, et al.
Human Reproduction (Oxford, England)|May 10, 2007
Pharmacokinetic profiles up to 12 h after administration of vaginal, sublingual and slow-release oral misoprostolA Aronsson, C Fiala, O Stephansson, et al.
Human Reproduction (Oxford, England)|August 2, 2005
Pharmacokinetics of a novel oral slow-release form of misoprostolC Fiala, A Aronsson, F Granath, et al.
Acta Dermato-Venereologica|January 1, 1987
Oral retinoids in mycosis fungoides and Sézary syndrome: a comparison of isotretinoin and etretinate. A study from the Scandinavian Mycosis Fungoides GroupL Molin, K Thomsen, G Volden, et al.
European Journal of Clinical Nutrition|September 14, 2017
Vitamin D and probiotics supplement use in young children with genetic risk for type 1 diabetesJ Yang, R N Tamura, U M Uusitalo, et al.
The New England Journal of Medicine|July 3, 2014
Risk of pediatric celiac disease according to HLA haplotype and countryEdwin Liu, Hye-Seung Lee, Carin A Aronsson, et al.
Journal of Pediatric Gastroenterology and Nutrition|July 29, 2017
Cesarean Section on the Risk of Celiac Disease in the Offspring: The Teddy StudySibylle Koletzko, Hye-Seung Lee, Andreas Beyerlein, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Human Reproduction (Oxford, England)|July 27, 2007
Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trialI Sääv, A Aronsson, L Marions, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|January 1, 1996
In vivo effects of 13-cis retinoic acid treatment on the concentration of proteins and lipids in serumG A Fex, A Aronsson, A Andersson, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|September 12, 2017
Vaginal breech delivery at term and neonatal morbidity and mortality - a population-based cohort study in SwedenC Ekéus, M Norman, K Åberg, et al.
European Journal of Clinical Nutrition|July 30, 2009
Ability of physical activity measurements to assess health-related risksC Li, C A Aronsson, B Hedblad, et al.
Human Reproduction (Oxford, England)|May 10, 2007
Pharmacokinetic profiles up to 12 h after administration of vaginal, sublingual and slow-release oral misoprostolA Aronsson, C Fiala, O Stephansson, et al.
Human Reproduction (Oxford, England)|August 2, 2005
Pharmacokinetics of a novel oral slow-release form of misoprostolC Fiala, A Aronsson, F Granath, et al.
Acta Dermato-Venereologica|January 1, 1987
Oral retinoids in mycosis fungoides and Sézary syndrome: a comparison of isotretinoin and etretinate. A study from the Scandinavian Mycosis Fungoides GroupL Molin, K Thomsen, G Volden, et al.
European Journal of Clinical Nutrition|September 14, 2017
Vitamin D and probiotics supplement use in young children with genetic risk for type 1 diabetesJ Yang, R N Tamura, U M Uusitalo, et al.
The New England Journal of Medicine|July 3, 2014
Risk of pediatric celiac disease according to HLA haplotype and countryEdwin Liu, Hye-Seung Lee, Carin A Aronsson, et al.
Journal of Pediatric Gastroenterology and Nutrition|July 29, 2017
Cesarean Section on the Risk of Celiac Disease in the Offspring: The Teddy StudySibylle Koletzko, Hye-Seung Lee, Andreas Beyerlein, et al.
Pageof 3